​

ADC Therapeutics Ownership | Who Owns ADC Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

ADC Therapeutics Ownership Summary

ADC Therapeutics is owned by 53.89% institutional investors, 20.64% insiders, and 25.46% retail investors. Redmile group is the largest institutional shareholder, holding 14.95% of ADCT shares. Biotech Growth Ord is the top mutual fund, with 2.15% of its assets in ADC Therapeutics shares.

ADCT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockADC Therapeutics53.89%20.64%25.46%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Redmile group15.67M14.95%$31.18M
Prosight management, lp9.52M9.08%$18.93M
Orbimed advisors5.97M5.69%$11.88M
Blackrock funding, inc. /de5.01M4.78%$9.97M
Blackrock3.55M4.31%$11.23M
Morgan stanley2.97M3.59%$9.37M
Woodline partners lp1.93M1.84%$3.85M
Goldman sachs group1.67M1.60%$3.33M
Platinum investment management1.61M1.54%$3.21M
Bank of america corp /de/1.22M1.47%$3.84M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Vantage consulting group850.74K16.14%$1.69M
Prosight management, lp9.52M5.23%$18.93M
Redmile group15.67M2.17%$31.18M
Blue owl capital lp733.57K0.34%$1.46M
Orbimed advisors5.97M0.25%$11.88M
Platinum investment management1.61M0.19%$3.21M
Dafna capital management224.08K0.11%$445.92K
Artal group1.02M0.08%$3.22M
Saxony capital management22.29K0.04%$44.35K
Woodline partners lp1.93M0.03%$3.85M

Top Buyers

HolderShares% AssetsChange
Blackrock3.55M0.00%3.55M
Woodline partners lp1.93M0.03%1.93M
Orbimed advisors5.97M0.25%1.43M
Artal group1.02M0.08%1.02M
Ubs group884.52K0.00%844.74K

Top Sellers

HolderShares% AssetsChange
Silverarc capital management---1.80M
Siren---1.16M
Adage capital partners gp---1.00M
Monashee investment management---500.00K
Affinity asset advisors---474.74K

New Positions

HolderShares% AssetsChangeValue
Blackrock3.55M0.00%3.55M$11.23M
Woodline partners lp1.93M0.03%1.93M$3.85M
Artal group1.02M0.08%1.02M$3.22M
Bnp paribas arbitrage, snc716.67K0.00%716.67K$1.43M
Northern trust23.01K-23.01K$72.72K

Sold Out

HolderChange
Gradient investments-11.00
Federation des caisses desjardins du quebec-20.00
Northwestern mutual wealth management-36.00
Global retirement partners-200.00
Cornerstone planning group-276.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024868.86%56,494,2772.93%531.97%49-5.77%1645.45%
Sep 30, 202478-54,783,5375.76%521.33%51-10.53%1183.33%
Jun 30, 20247895.00%51,801,95149.36%623.48%57185.00%6-25.00%
Mar 31, 2024408.11%34,683,5342.21%422.49%2053.85%8-20.00%
Dec 31, 202337-13.95%33,934,788-14.00%411.76%13-27.78%10-23.08%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Biotech Growth Ord2.13M2.15%-
iShares Russell 2000 ETF2.04M2.06%-17.66K
Fidelity Small Cap Index815.10K0.82%-15.26K
iShares Biotechnology ETF502.78K0.51%-5.60K
iShares Russell 2000 Growth ETF429.82K0.43%-2.04K
State St Russell Sm/Mid Cp® Indx NL Cl C401.24K0.41%-
State St Russell Sm/Mid Cp® Indx SL Cl I401.24K0.40%-
Vanguard Russell 2000 ETF370.40K0.37%8.64K
State St Russell Sm Cap® Indx SL Cl I305.70K0.31%-
iShares Russell 2000 Value ETF292.05K0.29%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 11, 2024Redmile Group, LLC-Buy$114.00K
Dec 11, 2024Redmile Group, LLC-Buy$190.50K
Dec 11, 2024Redmile Group, LLC-Buy$190.50K
Dec 11, 2024Redmile Group, LLC-Buy$114.00K
Dec 04, 2024Redmile Group, LLC-Sell$52.48K

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q441
2024 Q32-
2024 Q228
2024 Q120-

ADCT Ownership FAQ

Who Owns ADC Therapeutics?

ADC Therapeutics shareholders are primarily institutional investors at 53.89%, followed by 20.64% insiders and 25.47% retail investors. The average institutional ownership in ADC Therapeutics's industry, Biotech Stocks , is 68.48%, which ADC Therapeutics falls below.

Who owns the most shares of ADC Therapeutics?

ADC Therapeutics’s largest shareholders are Redmile group (15.67M shares, 14.95%), Prosight management, lp (9.52M shares, 9.08%), and Orbimed advisors (5.97M shares, 5.69%). Together, they hold 29.72% of ADC Therapeutics’s total shares outstanding.

Does Blackrock own ADC Therapeutics?

Yes, BlackRock owns 4.31% of ADC Therapeutics, totaling 3.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.23M$. In the last quarter, BlackRock increased its holdings by 3.55M shares, a 100.00% change.

Who is ADC Therapeutics’s biggest shareholder by percentage of total assets invested?

Vantage consulting group is ADC Therapeutics’s biggest shareholder by percentage of total assets invested, with 16.14% of its assets in 850.74K ADC Therapeutics shares, valued at 1.69M$.

Who is the top mutual fund holder of ADC Therapeutics shares?

Biotech Growth Ord is the top mutual fund holder of ADC Therapeutics shares, with 2.15% of its total shares outstanding invested in 2.13M ADC Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools